Your Partner in Life Sciences

Provides a Wide Range of Regulatory Services and Development Through Post-Market Support

International Life Science Inc. (ILSI)


These dedicated professionals collectively bring a wealth of knowledge and experience to International Life Science Enterprise Inc, enabling the company to deliver top-tier regulatory services and excel in post-market support.


At International Life Science Enterprises Inc, we are on a mission to amplify the global impact of life science companies. Our focus lies in the meticulous development and seamless implementation of regulatory strategies.

Market Analysis

Our agile and adaptive strategy allows us to stay ahead, leveraging the latest technologies to overcome barriers and ensure our clients thrive in the ever-evolving global business ecosystem.

International Life Science Inc. (ILSI)

Accelerating Your Commercialization Pathway
in the Market

Who We Are

Welcome to International Life-Science Enterprises Inc. (ILSE). Our mission is to increase the global reach of life science companies. The International Life-Science Enterprises program is dedicated to successfully establishing life science companies in specific global markets. All new prospective client markets are analyzed from cultural and fiscal perspectives, which determines market approaches and defines that market's opportunities. Each market presents both barriers and opportunities. ILSE identifies these objectively, presents them to our clients, and proposes maximizing and optimizing each opportunity.

We help our U.S. clients gain access to foreign markets by developing the necessary strategies and executing the associated tactics. Similarly, we assist our international clients in gaining access to the North American market by providing strategic, analytical, regulatory, and management assistance in Canada and the U.S.

The culture, technologies, and people are available to fully maximize the global market's opportunities to large multinational groups and early and mid-stage organizations, facilitating entry into global and domestic strategic relationships.

The ILSE group comprises experts in various aspects of the life science business, integrated with enthusiasm and extensive knowledge of the world's markets. This international cadre can deal with the complexities each world market represents. Today's technology enables a virtual approach to companies' challenges in reaping the benefits of globalization.

The first step to working with ILSE involves a pre-market SWOT analysis. Depending on the company's specific needs, products, and technology, this process can be a deep or shallow analysis. This procedure will determine the probability of your market success. Identifying and itemizing barriers, opportunities, potential partners, clients, and budgetary considerations will facilitate or impede market success. Given that this process indicates a positive potential, The next step will be to develop the necessary strategies and associated tactics required to be executed to ensure successful market entry. In some cases, it may identify significant barriers to market entry and describe these potential challenges and their potential resolution.


Fun Fact

Minnesota, home to the world’s major medical device companies such as Medtronic and Boston Scientific.

Also, the worst winter weather that keeps people working as nothing else to do when temp is below freezing. Sometimes so cold that Celsius and Fahrenheit meet (-40) – too cold for beer


Facilitates the establishment of life science companies in the USA and Canadian markets by conducting clinical trials, market evaluation, strategic advice, funding, strategic partnering, and gaining regulatory approvals. Interim management .


ILSE provides a partner in introducing international products into the growing and lucrative North American markets. We evaluate your products potential and provide provisional forecast and overall barriers to entry and their resolution. We are a small group dedicating ourselves to only those clients to whom we can bring success.


We assume that some organizations that wish to expand into the North American market and to optimize their probability of success while budgeting their funds carefully will take advantage of our services. We view our clients as our business partners.

Showcase – Background

  • Multinational partnership for vaccine company in excess of $3 million
    Conducted clinical trials for medical devices
  • FDA approval for Canadian and Japanese medical devices
  • Represented Asian economic development groups in the US to assist their members in accessing the North American markets
  • Conduct seminars on the challenges and opportunities of the US market and complex compensation structures
  • Worked with academic institutions wishing to establish relationships with partner institutions in the US
  • Working with major Japanese, Chinese, Middle Eastern and US multi-national Companies and start-ups.
International Life Science Inc. (ILSI)


International Life Science Inc. (ILSI)


fmf_V5GDWOm (1)

Market Analysis